NCT05307081View on ClinicalTrials.gov

An Observational, Qualitative Study Assessing Eye Drop Administration

UnknownOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

April 21, 2022

Primary Completion Date

July 31, 2023

Study Completion Date

December 31, 2023

Conditions
Ocular Injury
Interventions
DRUG

Artificial Tears

Artificial Tears are an FDA approved intervention

Trial Locations (1)

57108

RECRUITING

Vance Thompson Vision, Sioux Falls

Sponsors
All Listed Sponsors
lead

Ocular Therapeutix, Inc.

INDUSTRY